Last update:
Oncology news
Targeted IL-15 drug in patient testing revives exhausted T cells without triggering severe inflammation
For some people, cancer immunotherapies are life-changing. These treatments can turn the body's own immune system against a tumor, either eliminating it or shrinking it enough to make surgery possible. But these therapies ...
7 hours ago
0
3
Faster aging in younger generations linked to rise in early-onset cancer
Cancer is often considered a disease of aging. Older adults are at higher risk because they have had more time to accumulate cellular damage that can trigger tumor formation. But as cancer rates in younger adults rise, with ...
7 hours ago
0
0
Copper-induced cell death may help overcome immunotherapy resistance
A preclinical study by researchers at The University of Texas MD Anderson Cancer Center, published in Cell, details a connection between the immune system and cuproptosis, a type of copper-induced cell death. The findings ...
9 hours ago
0
2
Quantum-inspired AI could tailor patients' cancer treatment to their entire molecular background
For a child diagnosed with neuroblastoma—the most common infant cancer, occurring when early nerve cells grow out of control—the path to treatment isn't simple. Some types of neuroblastoma resolve on their own, while others ...
10 hours ago
0
3
Wearable devices may help detect cytokine release syndrome earlier in patients receiving CAR-T therapy
Researchers at the Icahn School of Medicine at Mount Sinai have found that wearable devices may help clinicians detect cytokine release syndrome (CRS)—a common and potentially serious side effect of CAR-T cell therapy—hours ...
8 hours ago
0
2
Lab-grown neurofibromatosis 1 tumors reveal how benign growths turn malignant
A research team from the Germans Trias i Pujol Research Institute (IGTP) has developed a new experimental model based on induced pluripotent stem cells (iPSCs) that makes it possible to reproduce in the laboratory the progression ...
8 hours ago
0
1
AI-based tissue anomaly detection may reduce duration of liver cancer surgery
A liver cancer diagnosis frequently leads to surgery, with the goal of completely removing all malignant tissue. To ensure that no tumor remains in the organ, the resected tissue is subjected to frozen-section analysis during ...
8 hours ago
0
1
Colon cancer cells may change identity to metastasize
Loss of GATA6—a transcription factor that controls which genes are turned on or off—can reprogram colorectal cancer cells into more primitive, adaptable states that can then spread to the liver and establish new tumors, according ...
9 hours ago
0
2
Prostate cancer screening discussions are rare, but make a big difference, according to study
Millions of men face a decision about whether to be screened for prostate cancer. National guidelines say that decision should begin with a conversation about the risks and benefits of testing. But a new Medical University ...
3 hours ago
0
0
AI and 3D-printed tumor organoids could rapidly uncover promising cancer therapies
Researchers at the UCLA Health Jonsson Comprehensive Cancer Center have developed a new platform that combines 3D bioprinting, advanced imaging and artificial intelligence to better monitor how cancer responds to treatment. ...
6 hours ago
0
0
Middle-aged women drink more, know less about breast cancer risk
Middle-aged women have the highest levels of problematic alcohol use, a new national survey shows, yet they may be the least aware that drinking can increase breast cancer risk.
4 hours ago
0
0
Biopsy-to-biomarker results still take 27 days for lung cancer, according to study
Even as biomarker testing has become increasingly important for selecting the right lung cancer treatment, the time it takes to order these tests hasn't improved. Overall, the time from biopsy to biomarker results is about ...
6 hours ago
0
0
SCD1 enzyme in lipid metabolism sheds light on resistance of certain cancers to treatment
The Cancer Metabolism and Tumor Microenvironment Laboratory at the University of Liège has uncovered a previously unrecognized mechanism that promotes cancer cell survival under therapeutic pressure. Published in MedComm, ...
6 hours ago
0
0
Chatbot-provided information about alcohol consumption and breast cancer risk is inconsistent, new study finds
Artificial intelligence (AI) is loosely defined as a narrow form of data-driven intelligence exhibited by machines. Generative AI (GenAI) creates new content based on learned patterns and supports online chatbots such as ...
17 hours ago
0
7
How neutrophils help triple-negative breast cancer cells spread
Researchers at Baylor College of Medicine and collaborating institutions have discovered how immune cells called neutrophils can help triple-negative breast cancer (TNBC) cells metastasize to other organs. The study, published ...
15 hours ago
0
2
Certain demographic, birth, and parental characteristics may increase risk of early-onset colorectal cancer
A recent study has found that factors such as a person's birth weight, sex, ethnicity and father's age may affect their risk of being diagnosed with colorectal cancer at a young age. The findings are published in Cancer.
21 hours ago
0
6
Advice for physicians on supporting teens and young adults living with cancer
Adolescents and young adults (AYA) living with and beyond cancer have unique needs and perspectives that clinicians should be aware of when providing health care. A practice article in the Canadian Medical Association Journal ...
Jun 22, 2026
0
3
Mass spectrometry platform could shrink cancer drug discovery cycle to four hours
Researchers at the Purdue Institute for Cancer Research (PICR) have developed a next-generation technology platform designed to accelerate one of the slowest and most challenging stages of cancer drug discovery: identifying ...
Jun 20, 2026
0
20
Only a third of eligible breast cancer patients receive a gene expression test
A gene expression test can help prevent unnecessary chemotherapy in breast cancer patients, yet its use in the Netherlands remains limited. This is shown by new research from the Netherlands Comprehensive Cancer Centre (IKNL), ...
Jun 20, 2026
0
24
Survey reveals major gaps in cardio-oncology training
An international survey has highlighted major gaps in cardio-oncology training, despite its increasing clinical importance. These results were presented at ESC Cardio-Oncology 2026, the second annual conference of the European ...
Jun 20, 2026
0
4
A renewable cell source for cancer immunotherapy could make off-the-shelf treatments possible
In a paper published in Cell, a USC Stem Cell-led team reports a new way of generating a renewable and expandable supply of the progenitor cells that give rise to macrophages. These immune cells help drive the body's response ...
Jun 19, 2026
0
42
One gene deletion tears off colon cancer's invisibility cloak, boosting immunotherapy
A study from the University of Calgary shows that removing a single gene makes colon cancer cells a target for immunotherapy—a fundamental breakthrough. The research, published in Cell Reports Medicine, was led by Dr. Arshad ...
Jun 19, 2026
0
16
Quick optical biopsy could be early detection method for endometrial cancer
Endometrial cancer is the most common gynecologic cancer, with more than 69,000 cases diagnosed in the U.S. in 2025 and increasing by up to 3% annually. Diagnosis requires an often painful, invasive biopsy that carries a ...
Jun 19, 2026
0
8
Targeting enzyme could block cancer spread to brain with fewer side effects
A new study has identified a more precise and effective way to prevent cancer from spreading to the brain. The paper, published in the Proceedings of the National Academy of Sciences, details the development of novel drug ...
Jun 19, 2026
0
8
FDA approves Welireg with pembrolizumab for renal cell carcinoma
The U.S. Food and Drug Administration has approved Merck's Welireg (belzutifan) in combination with pembrolizumab or pembrolizumab and berahyaluronidase alfa-pmph (Keytruda Qlex) for the adjuvant treatment of renal cell carcinoma ...
Jun 19, 2026
0
6
